RESUMO
Se valora la implantación de un protocolo de recuperación de sangre de los drenajes en cirugías de prótesis de rodilla. Estudio prospectivo con 19 pacientes diagnosticados de artrosis de rodilla y sometidos a cirugía de ATR, de septiembre a junio (2006-2007). El dispositivo utilizado fue Bellovac® de Astral Tech. No hubo diferencia de sexo y/o edad entre los pacientes transfundidos y no. En la URPA recibieron transfusión homóloga cuatro pacientes (21,50%). Previo a la implantación de este protocolo la incidencia de transfusión fue de 37%. La hemoglobina en el preoperatorio no fue factor de riesgo de transfusión homóloga. Éste se asoció, con el volumen drenado y reinfundido. Los pacientes transfundidos habían drenado 450 cc o más. No se registró ninguna complicación con el uso del recuperador. El uso del mismo permite disminuir la transfusión de sangre homóloga(AU)
The authors evaluate the adoption of a protocol to recuperate blood from drainage during surgery for knee prosthesis. They carried out a prospective study on 19 patients diagnosed with knee arthrosis and who underwent surgery for Total Knee Arthroplasty from September 2006 through June 2007. The medical instrument used was Bellovac®, produced by Astral Tech. In the Post anesthesia Reanimation Unit, four patients received a homologous transfusion (21.50%). Prior to the adoption of this protocol, the rate of transfusion was 37%. Hemoglobin during preoperative procedures was not a risk factor for a homologous transfusion. This is associated with the volume drained and reinserted. Patients who received a transfusion had drained 450 cc or more. The study did not record any complication due to the use of the recuperating device. The use of this device made it possible to decrease homologous blood transfusions(AU)
Assuntos
Humanos , Hemorragia Pós-Operatória/terapia , Perda Sanguínea Cirúrgica/enfermagem , Artroplastia do Joelho/métodos , Osteoartrite do Joelho/cirurgia , Fatores de Risco , Transfusão de SangueRESUMO
The authors evaluate the adoption of a protocol to recuperate blood from drainage during surgery for knee prosthesis. They carried out a prospective study on 19 patients diagnosed with knee arthrosis and who underwent surgery for Total Knee Arthroplasty from September 2006 through June 2007. The medical instrument used was Bellovac, produced by Astral Tech. In the Post anesthesia Reanimation Unit, four patients received a homologous transfusion (27.50%). Prior to the adoption of this protocol, the rate of transfusion was 37%. Hemoglobin during preoperative procedures was not a risk factor for a homologous transfusion. This is associated with the volume drained and reinserted. Patients who received a transfusion had drained 450 cc or more. The study did not record any complication due to the use of the recuperating device. The use of this device made it possible to decrease homologous blood transfusions.
